Immune checkpoint inhibitors or targeted therapy by mismatch repair status in endometrial cancer: a meta-analysis.

Future Sci OA · 2025 · PMC12355709 · PMID 40804781

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among the treatment options, Dostarlimab + CP had the highest SUCRA score (0.93) and tended to improve OS compared with CP alone (HR: 0.79; 95% CI: 0.60, 1.04), although these results did not reach statistical significance ( Figure 4d ; Supplementary Table 6 ; Supplementary Figure 6 ). 3.8.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.